Skip to content
Inteligencia IAMay 15, 2026Inteligencia IA
Articulo

Citius Oncology reported positive progress in the launch of LYMPHIR®.

First-half fiscal 2026 revenue reached $5.6 million, with broad payer coverage already established.

Redaccion Data Cube AIFuente: PR Newswire
01

Resumen fuente

Citius Oncology reported positive progress in the launch of LYMPHIR®. First-half fiscal 2026 revenue reached $5.6 million, with broad payer coverage already established.